Dataset Information

Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.

ABSTRACT: Antimicrobial proteins and peptides (AMPs) are essential effectors of innate immunity, acting as a first line of defense against bacterial infections. Many AMPs exhibit high affinity for cell wall structures such as lipopolysaccharide (LPS), a potent endotoxin able to induce sepsis. Hence, understanding how AMPs can interact with and neutralize LPS endotoxin is of special relevance for human health. Eosinophil cationic protein (ECP) is an eosinophil secreted protein with high activity against both Gram-negative and Gram-positive bacteria. ECP has a remarkable affinity for LPS and a distinctive agglutinating activity. By using a battery of LPS-truncated E. coli mutant strains, we demonstrate that the polysaccharide moiety of LPS is essential for ECP-mediated bacterial agglutination, thereby modulating its antimicrobial action. The mechanism of action of ECP at the bacterial surface is drastically affected by the LPS structure and in particular by its polysaccharide moiety. We have also analyzed an N-terminal fragment that retains the whole protein activity and displays similar cell agglutination behavior. Conversely, a fragment with further minimization of the antimicrobial domain, though retaining the antimicrobial capacity, significantly loses its agglutinating activity, exhibiting a different mechanism of action which is not dependent on the LPS composition. The results highlight the correlation between the protein's antimicrobial activity and its ability to interact with the LPS outer layer and promote bacterial agglutination.

SUBMITTER: Pulido D

PROVIDER: S-EPMC3346588 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.

Pulido David D Moussaoui Mohammed M Andreu David D Nogués M Victòria MV Torrent Marc M Boix Ester E

Antimicrobial agents and chemotherapy 20120213 5

Antimicrobial proteins and peptides (AMPs) are essential effectors of innate immunity, acting as a first line of defense against bacterial infections. Many AMPs exhibit high affinity for cell wall structures such as lipopolysaccharide (LPS), a potent endotoxin able to induce sepsis. Hence, understanding how AMPs can interact with and neutralize LPS endotoxin is of special relevance for human health. Eosinophil cationic protein (ECP) is an eosinophil secreted protein with high activity against bo ...[more]

PMID: 22330910

Similar Datasets

Project description:We report on an active nanocarrier for chlorhexidine (CHX) based on sterically stabilized shellac nanoparticles (NPs) with dual surface functionalization, which greatly enhances the antimicrobial action of CHX. The fabrication process for the CHX nanocarrier is based on pH-induced co-precipitation of CHX-DG from an aqueous solution of ammonium shellac and Poloxamer 407 (P407), which serves as a steric stabilizing agent. This is followed by further surface modification with octadecyl trimethyl ammonium bromide (ODTAB) through a solvent change to yield cationic surface functionality. In this study, we assessed the encapsulation efficiency and release kinetics of the novel nanocarrier for CHX. We further examined the antimicrobial effects of the CHX nanocarriers and their individual components in order to gain better insight into how they work, to improve their design and to explore the impacts of their dual functionalization. The antimicrobial actions of CHX loaded in shellac NPs were examined on three different proxy microorganisms: a Gram-negative bacterium (E. coli), a yeast (S. cerevisiae) and a microalgae (C. reinhardtii). The antimicrobial actions of free CHX and CHX-loaded shellac NPs were compared over the same CHX concentration range. We found that the non-coated shellac NPs loaded with CHX showed inferior action compared with free CHX due to their negative surface charge; however, the ODTAB-coated, CHX-loaded shellac NPs strongly amplified the antimicrobial action of the CHX for the tested microorganisms. The enhancement of the CHX antimicrobial action was thought to be due to the increased electrostatic adhesion between the cationic surface of the ODTAB-coated, CHX-loaded shellac NPs and the anionic surface of the cell walls of the microorganisms, ensuring direct delivery of CHX with a high concentration locally on the cell membrane. The novel CHX nanocarriers with enhanced antimicrobial action may potentially find applications in dentistry for the development of more efficient formulations against conditions such as gingivitis, periodontitis and other oral infections, as well as enabling formulations to have lower CHX concentrations.

Project description:Antimicrobial peptides are potent antibacterial agents. The subclass of short cationic RW-rich peptides is known to target the bacterial membrane. We employed the synthetic hexapeptide RWRWRW-NH2 to characterize in-depth the impact of short cationic RW-rich peptides on bacterial physiology and the bacterial response. Proteomics, ionomics, and amino acid analysis provided insights into both the mechanism of action and bacterial response. Peptide integration into the membrane depends on phospholipid composition and occurs in DPPG/DPPE mixed membranes but not in DPPG or DPPE membranes. Integration of the peptide changes lipid bilayer architecture resulting in delocalization of membrane-associated proteins involved in cell wall biosynthesis, respiration, and cell division. Consequently, cells suffer substantial energy limitation and cell wall integrity is corrupted. Bacteria react to this peptide stress by adjusting the membrane lipid composition andby modifying the cell wall. They further release osmoprotective amino acids, a novel strategy to survive exposure to bacteriolytic peptides. M&M Proteomics Treatment of B. subtilis 168, metabolic labeling of newly synthesized proteins with [35S]-L-methionine, and subsequent protein separation by 2D PAGE were performed as described previously [1]. For gel-free proteome analysis of membrane proteins B. subtilis 168 was grown aerobically at 37 °C in Belitzky minimal medium (BMM) supplemented with 14N-ammonium sulfate and 14N-L-tryptophane. Cells were stressed at an OD500 of 0.4 with 22.5 µg/mL MP196 for 65 minutes or left untreated as control. Untreated cultures grown on 15N-ammonium sulfate and 15N-L-tryptophane were used for relative quantification. Mixing of cell extracts prior to subcellular fractionation steps for relative quantification was carried out according to Otto et al [2].The enriched membrane protein fraction was prepared according to the workflow published by Eymann et al. [3] omitting the n-dodecyl-beta-D-maltoside treatment step. The preparation of the integral membrane peptides was carried out as described by Wolff et al.[4]. Sample preparation, mass spectrometric measurement, and subsequent data analysis were carried out as described by Otto et al.[2][1] Wenzel, M. et al.Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. Antimicrob. Agents Chemother. Doi:10.1128/AAC.01380-12 (2012) [2] Otto, a. et al. Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis. Nat Commun. 2010;1:137. doi: 10.1038/ncomms1137 [3] Eymann, C. et al. A comprehensive proteome map of growing Bacillus subtilis cells. Proteomics. 2004 Oct;4(10):2849-76 [4] Wolff, S. et al. Complementary analysis of the vegetative membrane proteome of the human pathogen Staphylococcus aureus.Mol Cell Proteomics. 2008 Aug;7(8):1460-8. doi: 10.1074/mcp.M700554-MCP200

Dataset Information

Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.

Publications

Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets